These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 9280455)

  • 1. [The effect of liposomal form of L-Dopa on the level of dopamine, its metabolites, and phospholipid metabolism in the striatum of mice with experimental parkinsonian syndrome].
    Iurasov VV; Podgornyĭ GI; Kucherianu VG; Kudrin VS; Nikushkin EV; Zhigal'tsev IV; Sandalov IuG; Kaplun AP; Shvets VI; Kryzhanovskiĭ GN
    Biull Eksp Biol Med; 1996 Dec; 122(12):614-7. PubMed ID: 9280455
    [No Abstract]   [Full Text] [Related]  

  • 2. [The effect of prolonged parenteral administration of liposomes and L-Dopa incorporated into liposomes on metabolism of dopamine and its metabolites in the striatum of mice with experimental parkinsonian syndrome].
    Iurasov VV; Kucherianu VG; Kudrin VS; Zhigal'tsev IV; Nikushkin EV; Sandalov IuG; Kaplun AP; Shvets VI
    Biull Eksp Biol Med; 1997 Feb; 123(2):150-3. PubMed ID: 9280483
    [No Abstract]   [Full Text] [Related]  

  • 3. [The effect of liposomal form of L-Dopa on the development of parkinsonian syndrome in mice].
    Kucherianu VG; Iurasov VV; Kryzhanovskiĭ GN; Nikushkin EV; Zhigal'tsev IV; Kaplun VP; Shvets VI
    Biull Eksp Biol Med; 1997 Jan; 123(1):29-33. PubMed ID: 9213451
    [No Abstract]   [Full Text] [Related]  

  • 4. Amine fluorescence histochemical investigation of the striatum in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine(MPTP)-induced parkinsonian mice.
    Mizukawa K; Ogawa N; Sora YH
    Res Commun Chem Pathol Pharmacol; 1988 Jan; 59(1):121-8. PubMed ID: 3258432
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interference of 3-O-methyldopa with L-dopa treatment for MPTP-induced parkinsonism in mice.
    Fujitake J; Kuno S; Mizuta E
    Adv Neurol; 1990; 53():225-9. PubMed ID: 2239462
    [No Abstract]   [Full Text] [Related]  

  • 6. [Effect of acidic fibroblast growth factor on experimental parkinsonism and levels of dopamine and its metabolites in the striatum of mice of various ages].
    Kucherianu VG; Kryzhanovskiĭ GN; Kudrin VS; Iurasov VV; Nikushkin EV; Zhigal'tsev IV
    Biull Eksp Biol Med; 1999 May; 127(5):502-5. PubMed ID: 10399565
    [No Abstract]   [Full Text] [Related]  

  • 7. Striatal extracellular dopamine levels and behavioural reversal in MPTP-lesioned mice.
    Kirchhoff J; Mørk A; Brennum LT; Sager TN
    Neuroreport; 2009 Mar; 20(5):482-6. PubMed ID: 19262413
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amantadine enhances dopamine and serotonin turnover in the MPTP model of Parkinson's disease.
    Altagracia M; Rojas P; Kravzov J; Rios C
    Proc West Pharmacol Soc; 1993; 36():289-91. PubMed ID: 7690973
    [No Abstract]   [Full Text] [Related]  

  • 9. The expression of the calcium binding protein calretinin in the rat striatum: effects of dopamine depletion and L-DOPA treatment.
    Mura A; Feldon J; Mintz M
    Exp Neurol; 2000 Aug; 164(2):322-32. PubMed ID: 10915571
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The effect of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine, liposomes with L-DOPA and "empty" liposomes on the phospholipid composition of the murine liver].
    Podgornyĭ GN; Namestnikova IV; Sliusar' NN
    Eksp Klin Farmakol; 1999; 62(1):41-4. PubMed ID: 10198765
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MPTP and aging. Studies in the C57BL/6 mouse.
    Irwin I; DeLanney LE; Langston JW
    Adv Neurol; 1993; 60():197-206. PubMed ID: 8420136
    [No Abstract]   [Full Text] [Related]  

  • 12. The effect of subchronic, intermittent L-DOPA treatment on neuronal nitric oxide synthase and soluble guanylyl cyclase expression and activity in the striatum and midbrain of normal and MPTP-treated mice.
    Chalimoniuk M; Langfort J
    Neurochem Int; 2007 May; 50(6):821-33. PubMed ID: 17379358
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Swim-test as a function of motor impairment in MPTP model of Parkinson's disease: a comparative study in two mouse strains.
    Haobam R; Sindhu KM; Chandra G; Mohanakumar KP
    Behav Brain Res; 2005 Sep; 163(2):159-67. PubMed ID: 15941598
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interleukine-1beta and interleukine-6 levels in striatum and other brain structures after MPTP treatment: influence of behavioral lateralization.
    Shen YQ; Hebert G; Lin LY; Luo YL; Moze E; Li KS; Neveu PJ
    J Neuroimmunol; 2005 Jan; 158(1-2):14-25. PubMed ID: 15589033
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of L-DOPA-therapy on dopamine D2 receptor mRNA expression in the striatum of MPTP-intoxicated parkinsonian monkeys.
    Herrero MT; Augood SJ; Asensi H; Hirsch EC; Agid Y; Obeso JA; Emson PC
    Brain Res Mol Brain Res; 1996 Nov; 42(1):149-55. PubMed ID: 8915594
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunohistochemical detection of L-DOPA-derived dopamine within serotonergic fibers in the striatum and the substantia nigra pars reticulata in Parkinsonian model rats.
    Yamada H; Aimi Y; Nagatsu I; Taki K; Kudo M; Arai R
    Neurosci Res; 2007 Sep; 59(1):1-7. PubMed ID: 17586078
    [TBL] [Abstract][Full Text] [Related]  

  • 17. l-dopa-induced reversal in striatal glutamate following partial depletion of nigrostriatal dopamine with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.
    Holmer HK; Keyghobadi M; Moore C; Meshul CK
    Neuroscience; 2005; 136(1):333-41. PubMed ID: 16198485
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neural mechanisms underlying motor dysfunction as detected by the tail suspension test in MPTP-treated C57BL/6 mice.
    Mori A; Ohashi S; Nakai M; Moriizumi T; Mitsumoto Y
    Neurosci Res; 2005 Mar; 51(3):265-74. PubMed ID: 15710490
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of L-DOPA on aggressive behavior and central monoaminergic activity in the lizard Anolis carolinensis, using a new method for drug delivery.
    Höglund E; Korzan WJ; Watt MJ; Forster GL; Summers TR; Johannessen HF; Renner KJ; Summers CH
    Behav Brain Res; 2005 Jan; 156(1):53-64. PubMed ID: 15474650
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo NMR studies of regional cerebral energetics in MPTP model of Parkinson's disease: recovery of cerebral metabolism with acute levodopa treatment.
    Bagga P; Chugani AN; Varadarajan KS; Patel AB
    J Neurochem; 2013 Nov; 127(3):365-77. PubMed ID: 23957451
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.